Protein biomarkers, including Amyloid-Beta (Aβ), tau, and ptau [AT(N)] have emerged as a potential indicator in identifying the complex molecular and cellular alterations linked with AD (Martí-Juan et al., 2020; Khan et al., 2023). This evidence concerns the gene MAPT and Alzheimer disease.